Patents by Inventor Matthieu Charveriat

Matthieu Charveriat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of flecainide as an anti-connexin agent and method for potentiating the effects of a psychotropic drug
    Patent number: 10639301
    Abstract: The present invention relates to the use of flecainide as an anti-connexin agent. This anti-connexin agent is advantageously used to potentiate the therapeutic effect of various psychotropic drugs. More specifically, the invention provides a combination product containing flecainide and modafinil.
    Type: Grant
    Filed: September 21, 2018
    Date of Patent: May 5, 2020
    Assignee: Commissariat a L'Energie Atomique et Aux Energies Alternatives
    Inventors: Franck Mouthon, Matthieu Charveriat
  • Use of Flecainide as an Anti-Connexin Agent and Method for Potentiating the Effects of a Psychotropic Drug
    Publication number: 20190008844
    Abstract: The present invention relates to the use of flecainide as an anti-connexin agent. This anti-connexin agent is advantageously used to potentiate the therapeutic effect of various psychotropic drugs. More specifically, the invention provides a combination product containing flecainide and modafinil.
    Type: Application
    Filed: September 21, 2018
    Publication date: January 10, 2019
    Inventors: Franck Mouthon, Matthieu Charveriat
  • Use of Flecainide as an Anti-Connexin Agent and Method for Potentiating the Effects of a Psychotropic Drug
    Publication number: 20180028519
    Abstract: The present invention relates to the use of flecainide as an anti-connexin agent. This anti-connexin agent is advantageously used to potentiate the therapeutic effect of various psychotropic drugs. More specifically, the invention provides a combination product containing flecainide and modafinil.
    Type: Application
    Filed: August 3, 2017
    Publication date: February 1, 2018
    Inventors: Franck Mouthon, Matthieu Charveriat
  • Use of Clonazepam in Combination with Antibiotic in the Treatment of Bacterially Induced Meningitis
    Publication number: 20160082016
    Abstract: The present invention relates to the use of a well-known benzodiazepine compound, namely clonazepam, in combination with antibiotic agents, for treating bacterially induced meningitis.
    Type: Application
    Filed: May 14, 2014
    Publication date: March 24, 2016
    Inventors: Franck Mouthon, Matthieu Charveriat